IPIX Innovation Pharmaceuticals Inc

Price (delayed)

$0.3015

Market cap

$126.07M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.04

Enterprise value

$115.02M

Highlights
Innovation Pharmaceuticals's equity has surged by 197% QoQ
Innovation Pharmaceuticals's quick ratio has soared by 68% from the previous quarter
Innovation Pharmaceuticals's gross profit has shrunk by 94% YoY
Innovation Pharmaceuticals's revenue has plunged by 94% YoY

Key stats

What are the main financial stats of IPIX
Market
Shares outstanding
418.16M
Market cap
$126.07M
Enterprise value
$115.02M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
12.35
Price to sales (P/S)
5,193.43
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5,001.02
Earnings
Revenue
$23,000
EBIT
-$12.61M
EBITDA
-$12.24M
Free cash flow
-$8.72M
Per share
EPS
-$0.04
Free cash flow per share
-$0.02
Book value per share
$0.02
Revenue per share
$0
TBVPS
$0.04
Balance sheet
Total assets
$16.92M
Total liabilities
$6.72M
Debt
$1.96M
Equity
$10.21M
Working capital
$6.64M
Liquidity
Debt to equity
0.19
Current ratio
2.03
Quick ratio
2.03
Net debt/EBITDA
0.9
Margins
EBITDA margin
-53,204.3%
Gross margin
100%
Net margin
-55,587%
Operating margin
-34,391.3%
Efficiency
Return on assets
-101.7%
Return on equity
-258.6%
Return on invested capital
N/A
Return on capital employed
-120.1%
Return on sales
-54,839.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IPIX stock price

How has the Innovation Pharmaceuticals stock price performed over time
Intraday
-5.78%
1 week
-4.29%
1 month
47.22%
1 year
22.96%
YTD
69.86%
QTD
39.91%

Financial performance

How have Innovation Pharmaceuticals's revenue and profit performed over time
Revenue
$23,000
Gross profit
$23,000
Operating income
-$7.91M
Net income
-$12.79M
Gross margin
100%
Net margin
-55,587%
Innovation Pharmaceuticals's gross profit has shrunk by 94% YoY
Innovation Pharmaceuticals's revenue has plunged by 94% YoY
The net income has plunged by 91% YoY and by 30% from the previous quarter
The operating income has plunged by 74% YoY and by 14% from the previous quarter

Growth

What is Innovation Pharmaceuticals's growth rate over time

Valuation

What is Innovation Pharmaceuticals stock price valuation
P/E
N/A
P/B
12.35
P/S
5,193.43
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5,001.02
The company's EPS fell by 33% QoQ and by 33% YoY
Innovation Pharmaceuticals's equity has surged by 197% QoQ
IPIX's price to book (P/B) is 61% lower than its last 4 quarters average of 31.8
Innovation Pharmaceuticals's revenue has plunged by 94% YoY
The P/S is 93% above the last 4 quarters average of 2685.7

Efficiency

How efficient is Innovation Pharmaceuticals business performance
Innovation Pharmaceuticals's return on equity has surged by 66% QoQ
Innovation Pharmaceuticals's return on assets has increased by 40% YoY and by 3.3% QoQ
The company's return on sales fell by 31% QoQ

Dividends

What is IPIX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IPIX.

Financial health

How did Innovation Pharmaceuticals financials performed over time
The company's total assets is 152% higher than its total liabilities
Innovation Pharmaceuticals's quick ratio has soared by 68% from the previous quarter
The current ratio has soared by 66% QoQ
The debt is 81% less than the equity
Innovation Pharmaceuticals's equity has surged by 197% QoQ
Innovation Pharmaceuticals's debt to equity has surged by 135% YoY but it has shrunk by 68% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.